Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Business Wire•02/11/2026•09:00 ET
0
Key Highlights
- ➤Amylyx will report third-quarter 2026 financial results November 5, 2026
- ➤Conference call and webcast scheduled for 8:00 a.m. ET
- ➤Amylyx is focused on four investigational therapies across endocrine and neurodegenerative diseases
Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its third quarter 2026 financial results on Thursday, November 5, 2026. Amylyx’s senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.
Get started
Create a free account to read the full story.